You are here: Home / Valorisation / Publications / 2017

Infos pratiques

Organigramme
Contacts
  • Directeur :

        Pr Eric DELAPORTE

  • Directeur Adjoint :

        Bernard TAVERNE

Accès à la Délégation Régionale IRD-Occitanie (Montpellier)

2017

Ayouba A., Touré A., Butel C., Keita A. K., Binetruy F., Sow M. S., Foulongne V., Delaporte E., et Peeters M.,
Development of a Sensitive and Specific Serological Assay Based on Luminex Technology for Detection of Antibodies to Zaire Ebola Virus,
J. Clin. Microbiol., vol. 55, no 1, p. 165‑176, janv. 2017. doi: 10.1128/JCM.01979-16.

Bonnet M., Kyakwera C., Kyomugasho N., Atwine D., Mugabe F., Nansumba M., Ii Y. B., Mwanga-Amumpaire J., et Kiwanuka J.,
Prospective cohort study of the feasibility and yield of household child tuberculosis contact screening in Uganda,
Int. J. Tuberc. Lung Dis., vol. 21, no 8, p. 862‑868, 01 2017. doi: 10.5588/ijtld.16.0889.

Ahuka Mundeke S., Ayouba A., Mbala-Kingebeni P., Foncelle C., Mubonga M., Ndimbo-Kumugo S.-P., Lunguya-Metila O., Mbenzo-Abokome V., Muyembe-Tamfum J.-J., Delaporte E., et Peeters M.,
High Prevalences and a Wide Genetic Diversity of Simian Retroviruses in Non-human Primate Bushmeat in Rural Areas of the Democratic Republic of Congo,
Ecohealth, janv. 2017. doi: 10.1007/s10393-016-1202-0

Ahuka-Mundeke S., Ayouba A., Mbala-Kingebeni P., Foncelle C., Mubonga M., Ndimbo-Kumugo S.-P., Lunguya-Metila O., Mbenzo-Abokome V., Muyembe-Tamfum J.-J., Delaporte E., et Peeters M.,
Erratum to: High Prevalences and a Wide Genetic Diversity of Simian Retroviruses in Non-human Primate Bushmeat in Rural Areas of the Democratic Republic of Congo,
Ecohealth, vol. 14, no 1, p. 115, mars 2017. doi: 10.1007/s10393-017-1223-3.

Schmidt F., Liegeois F., Greenwood E. J. D., LeBreton M., Lester J., Deleplancque L., Peeters M., Aghokeng A., Tamoufe U., Diffo J. L. D., Takuo J. M., Wolfe N. D., Leroy E., Rouet F., et Heeney J. L.,
Phyloepidemiological analysis reveals that viral divergence led to the paucity of SIVmus/gsn/mon infections in wild populations,
J. Virol., janv. 2017. doi: 10.1128/JVI.01884-16.

Bork K. A., Cames C., Newell M.-L., Read J. S., Ayassou K., Musyoka F., Mbatia G., Cournil A., et Kesho Bora Study Group,
Formula-Feeding of HIV-Exposed Uninfected African Children Is Associated with Faster Growth in Length during the First 6 Months of Life in the Kesho Bora Study,
J. Nutr., janv. 2017. doi: 10.3945/jn.116.242339.

Huerga H., Ferlazzo G., Bevilacqua P., Kirubi B., Ardizzoni E., Wanjala S., Sitienei J., et Bonnet M.,
Incremental Yield of Including Determine-TB LAM Assay in Diagnostic Algorithms for Hospitalized and Ambulatory HIV-Positive Patients in Kenya,
PLoS ONE, vol. 12, no 1, p. e0170976, janv. 2017. doi: 10.1371/journal.pone.0170976.

Akhoundi M., Downing T., Votýpka J., Kuhls K., Lukeš J., Cannet A., Ravel C., Marty P., Delaunay P., Kasbari M., Granouillac B., Gradoni L., et Sereno D.,
Leishmania infections: Molecular targets and diagnosis,
Mol. Aspects Med., janv. 2017. doi: 10.1016/j.mam.2016.11.012.

Subtil F., Boussari O., Bastard M., Etard J.-F., Ecochard R., et Génolini C.,
An alternative classification to mixture modeling for longitudinal counts or binary measures,
Stat Methods Med Res, vol. 26, no 1, p. 453‑470, févr. 2017. doi: 10.1177/0962280214549040.

Desclaux A., Badji D., Ndione A. G., et Sow K.,
Accepted monitoring or endured quarantine? Ebola contacts’ perceptions in Senegal,
Soc Sci Med, vol. 178, p. 38‑45, févr. 2017. doi: 10.1016/j.socscimed.2017.02.009.

Onywera H., Maman D., Inzaule S., Auma E., Were K., Fredrick H., Owiti P., Opollo V., Etard J.-F., Mukui I., Kim A. A., et Zeh C.,
Surveillance of HIV-1 pol transmitted drug resistance in acutely and recently infected antiretroviral drug-naïve persons in rural western Kenya,
PLoS ONE, vol. 12, no 2, p. e0171124, 2017. doi: 10.1371/journal.pone.0171124.

Ahuka-Mundeke S., Mbala-Kingebeni P., Ndimbo-Kumogo S.-P., Foncelle C., Lunguya-Metila O., Muyembe-Tamfum J.-J., Delaporte E., Peeters M., et Ayouba A.,
Full genome characterization of a new SIV lineage in a naturally infected Cercopithecus ascanius whitesidei in the Democratic Republic of Congo reveals high genetic diversity among red-tailed monkeys in Central and Eastern Africa,
AIDS Research and Human Retroviruses, févr. 2017. doi: 10.1089/AID.2017.0027.

Subtil F., Delaunay C., Keita A. K., Sow M., Touré A. I., Leroy S., Msellati P., Magassouba N., Baize S., Raoul H., Ecochard R., Barry M., Delaporte E., Etard J.-F., et Postebogui Study Group,
Dynamics of Ebola RNA persistence in semen: report from the Postebogui cohort in Guinea,
Clin. Infect. Dis., mars 2017. doi: 10.1093/cid/cix210.

Bork K. A. et Diallo A.,
Boys Are More Stunted than Girls from Early Infancy to 3 y of Age in Rural Senegal,
J. Nutr.,mars 2017. doi: 10.3945/jn.116.243246.

Pers Y.-M., Sow M. S., Taverne B., March L., Izard S., Étard J. F., Barry M., Touré A., et Delaporte E.,
Characteristics of the musculoskeletal symptoms observed among survivors of Ebola virus disease in the Postebogui cohort in Guinea,
Rheumatology (Oxford), mars 2017. doi: 10.1093/rheumatology/kex074.

Ndam N. T., Basco L. K., Ngane V. F., Ayouba A., Ngolle E. M., Deloron P., Peeters M., et Tahar R.,
Reemergence of chloroquine-sensitive pfcrt K76 Plasmodium falciparum genotype in southeastern Cameroon,
Malar. J., vol. 16, no 1, p. 130, mars 2017. doi: 10.1186/s12936-017-1783-2.

Wroblewski E. E., Guethlein L. A., Norman P. J., Li Y., Shaw C. M., Han A. S., Ndjango J.-B. N., Ahuka-Mundeke S., Georgiev A. V., Peeters M., Hahn B. H., et Parham P.,
Bonobos Maintain Immune System Diversity with Three Functional Types of MHC-B,
J. Immunol., mars 2017. doi: 10.4049/jimmunol.1601955.

Pion S. D. S., Chesnais C. B., Weil G. J., Fischer P. U., Missamou F., et Boussinesq M.,
Effect of 3 years of biannual mass drug administration with albendazole on lymphatic filariasis and soil-transmitted helminth infections: a community-based study in DRC
Lancet Infect Dis, mars 2017. doi: 10.1016/S1473-3099(17)30175-5.

Acuña-Villaorduña C., Orikiriza P., Nyehangane D., White L. F., Mwanga-Amumpaire J., Kim S., Bonnet M., Fennelly K. P., Boum Y., et Jones-López E. C.,
Effect of previous treatment and sputum quality on diagnostic accuracy of Xpert(®) MTB/RIF,
Int. J. Tuberc. Lung Dis., vol. 21, no 4, p. 389‑397, avr. 2017. doi: 10.5588/ijtld.16.0785.

Keita M. M., Taverne B., Sy Savané S., March L., Doukoure M., Sow M. S., Touré A., Etard J. F., Barry M., Delaporte E., et PostEboGui Study Group,
Depressive symptoms among survivors of Ebola virus disease in Conakry (Guinea): preliminary results of the PostEboGui cohort,
BMC Psychiatry, vol. 17, no 1, p. 127, avr. 2017. doi: 10.1186/s12888-017-1280-8.

Taieb F., Madec Y., Cournil A., et Delaporte E.,
Virological success after 12 and 24 months of antiretroviral therapy in sub-Saharan Africa: Comparing results of trials, cohorts and cross-sectional studies using a systematic review and meta-analysis,
PLoS ONE, vol. 12, no 4, p. e0174767, 2017. doi: 10.1371/journal.pone.0174767.

Atwine D., Orikiriza P., Taremwa I., Ayebare A., Logoose S., Mwanga-Amumpaire J., Jindani A., et Bonnet M.,
Predictors of delayed culture conversion among Ugandan patients,
BMC Infect. Dis., vol. 17, no 1, p. 299, avr. 2017. doi: 10.1186/s12879-017-2335-7.

Younas M., Psomas C., Mehraj V., Cezar R., Portales P., Tuaillon E., Guigues A., Reynes J., Corbeau P., et Routy J.-P.,
Plasma Level of Soluble ST2 in Chronically Infected HIV-1 Patients with Suppressed Viremia,
Open AIDS J, vol. 11, p. 32‑35, avr. 2017. doi: 10.2174/1874613601711010032.

Etard J.-F., Sow M. S., Leroy S., Touré A., Taverne B., Keita A. K., Msellati P., Magassouba N., Baize S., Raoul H., Izard S., Kpamou C., March L., Savane I., Barry M., Delaporte E., et Postebogui Study Group,
Multidisciplinary assessment of post-Ebola sequelae in Guinea (Postebogui): an observational cohort study,
Lancet Infect Dis, vol. 17, no 5, p. 545‑552, mai 2017. doi: 10.1016/S1473-3099(16)30516-3.

Boyer V., Vilotitch A., Marcellin F., Demoulin B., Dray-Spira R., Spire B., et ANRS-VESPA2 Study Group,
Self-Reported Bothersome Symptoms Across Different Socioepidemiological Groups of People Living with HIV Attending French Hospitals: Results from the ANRS-VESPA2 Survey,
J Pain Symptom Manage, mai 2017. doi: 10.1016/j.jpainsymman.2017.03.010.

Bommart S., Cournil A., Eymard-Duvernay S., Raffi F., Bouassida I., Le Moing V., Reynes J., Makinson A., et Agence Nationale de Recherche sur le Sida et les Hépatites Virales (ANRS) HIV CHEST Study Team,
Smoking-associated morbidities on computed tomography lung cancer screens in HIV-infected smokers,
HIV Med., mai 2017. doi: 10.1111/hiv.12517

Kosack C. S., Spijker S., Halton J., Bonnet M., Nicholas S., Chetcuti K., Mesic A., Brant W. E., Joekes E., et Andronikou S.,
Evaluation of a chest radiograph reading and recording system for tuberculosis in a HIV-positive cohort,
Clin Radiol, vol. 72, no 6, p. 519.e1-519.e9, juin 2017. doi: 10.1016/j.crad.2017.01.008.

Keita A. K., Toure A., Sow M. S., Raoul H., Magassouba N., Delaporte E., Etard J.-F., et POSTEBOGUI Study Group,
Extraordinary long-term and fluctuating persistence of Ebola virus RNA in semen of survivors in Guinea: implications for public health,
Clin. Microbiol. Infect., vol. 23, no 6, p. 412‑413, 2017. doi: 10.1016/j.cmi.2016.11.005.

Barankanira E., Molinari N., Msellati P., Laurent C., et Bork K. A.,
Stunting among children under 3 years of age in Côte d’Ivoire: spatial and temporal variations between 1994 and 2011,
Public Health Nutr, vol. 20, no 9, p. 1627‑1639, juin 2017. doi: 10.1017/S1368980017000544.

Zhou Y. R., Coleman W. D., Huang Y., Sinding C., Wei W., Gahagan J., Micollier E., et Su H. H.,
Exploring the intersections of transnationalism, sexuality and HIV risk,
Cult Health Sex, vol. 19, no 6, p. 645‑652, juin 2017. doi: 10.1080/13691058.2017.1300327.

Barankanira E., Desclaux Sall C., Guichet E., Ky-Zerbo O., Nana Djeunga H. C., Ngom Gueye N. F., Servais S., et Varloteaux M.,
Ethics of health research partnerships in Global South : PhD students in learning,
Med Sante Trop, vol. 27, no 2, p. 122‑125, juin 2017. doi: 10.1684/mst.2017.0676.

Pradat P., Pugliese P., Poizot-Martin I., Valantin M.-A., Cuzin L., Reynes J., Billaud E., Huleux T., Bani-Sadr F., Rey D., Frésard A., Jacomet C., Duvivier C., Cheret A., Hustache-Mathieu L., Hoen B., Cabié A., Cotte L., et Dat’AIDS study Group,
Direct-Acting Antiviral Treatment against Hepatitis C Virus infection in HIV-Infected Patients - « En route for eradication »?,
J. Infect., juin 2017. doi: 10.1016/j.jinf.2017.05.008.

Appelgren A., Morquin D., Dufour S., Le Moing V., Reynes J., Lotthé A., Parer S., Corbeau C., Aubry A., Sougakoff W., Solassol J., Bonzon L., Dumont Y., et Godreuil S.,
Investigation of a pre-XDR Beijing Mycobacterium tuberculosis transmission to a healthcare worker in France, 2016,
J. Hosp. Infect., juin 2017. doi: 10.1016/j.jhin.2017.06.030.

Bonnet M., San K. C., Pho Y., Sok C., Dousset J.-P., Brant W., Hurtado N., Eam K. K., Ardizzoni E., Heng S., Godreuil S., Yew W.-W., et Hewison C.,
Nontuberculous Mycobacteria Infections at a Provincial Reference Hospital, Cambodia,
Emerging Infect. Dis., vol. 23, no 7, p. 1139‑1147, juill. 2017. doi: 10.3201/eid2307.170060.

Doyle S. R., Bourguinat C., Nana-Djeunga H. C., Kengne-Ouafo J. A., Pion S. D. S., Bopda J., Kamgno J., Wanji S., Che H., Kuesel A. C., Walker M., Basáñez M.-G., Boakye D. A., Osei-Atweneboana M. Y., Boussinesq M., Prichard R. K., et Grant W. N.,
Genome-wide analysis of ivermectin response by Onchocerca volvulus reveals that genetic drift and soft selective sweeps contribute to loss of drug sensitivity,
PLoS Negl Trop Dis, vol. 11, no 7, p. e0005816, juill. 2017. doi: 10.1371/journal.pntd.0005816.

Guglielmetti L., Varaine F., Huerga H., Bonnet M., Rich M. L., et Mitnick C. D.,
Shortened multidrug-resistant tuberculosis treatment in settings with a high prevalence of ofloxacin resistance,
Eur. Respir. J., vol. 50, no 1, juill. 2017. doi: 10.1183/13993003.00598-2017.

Couderc C., Keita B. D., Anoma C., Wade A. S., Coulibaly A., Ehouman S., Diop A. K., Yomb Y., Henry E., Spire B., et Laurent C.,
Is PrEP needed for MSM in West Africa? HIV incidence in a prospective multi-country cohort,
J. Acquir. Immune Defic. Syndr., vol. 75, no 3, p. e80‑e82, juill. 2017. doi: 10.1097/QAI.0000000000001288.

Desclaux A.,
[The silent disappearance of PADHUE doctors: the end of a State injustice or a new form of exclusion?],
Sante Publique, vol. 29, no 3, p. 341‑344, juill. 2017.

Hancart Petitet P.,
Abortion politics in Cambodia social history, local forms and transnational issues,
Glob Public Health, p. 1‑10, juill. 2017. doi: 10.1080/17441692.2017.1354228.

Walker M., Pion S. D. S., Fang H., Gardon J., Kamgno J., Basáñez M.-G., et Boussinesq M.,
The macrofilaricidal efficacy of repeated doses of ivermectin for the treatment of river blindness,
Clin. Infect. Dis., juill. 2017. doi: 10.1093/cid/cix616.

Gatti G., Perrotti A., Obadia J.-F., Duval X., Iung B., Alla F., Chirouze C., Selton-Suty C., Hoen B., Sinagra G., Delahaye F., Tattevin P., Le Moing V., Pappalardo A., Chocron S., et Association for the Study and Prevention of Infective Endocarditis Study Group–Association pour l’Étude et la Prévention de l’Endocadite Infectieuse (AEPEI),
Simple Scoring System to Predict In-Hospital Mortality After Surgery for Infective Endocarditis,
J Am Heart Assoc, vol. 6, no 7, juill. 2017. doi: 10.1161/JAHA.116.004806.

Blaizot S., Huerga H., Riche B., Ellman T., Shroufi A., Etard J.-F., et Ecochard R.,
Combined interventions to reduce HIV incidence in KwaZulu-Natal: a modelling study,
BMC Infect. Dis., vol. 17, no 1, p. 522, juill. 2017. doi: 10.1186/s12879-017-2612-5.

Hereth Hébert E., Resnikoff S., March L., et Delaporte E.,
Ocular Complications in Survivors of the Ebola Outbreak in Guinea,
Am. J. Ophthalmol., juill. 2017. doi: 10.1016/j.ajo.2017.06.032.

Villabona Arenas C. J., Vidal N., Ahuka Mundeke S., Muwonga J., Serrano L., Muyembe J. J., Boillot F., Delaporte E., et Peeters M.,
Divergent HIV-1 strains (CRF92_C2U and CRF93_cpx) co-circulating in the Democratic Republic of the Congo: Phylogenetic insights on the early evolutionary history of subtype C,
Virus Evol, vol. 3, no 2, p. vex032, juill. 2017. doi: 10.1093/ve/vex032.

Ngouana T. K., Drakulovski P., Krasteva D., Toghueo R. K., Kouanfack C., Reynes J., Delaporte E., Boyom F. F., Mallié M., et Bertout S.,
Genetic diversity of the Hwp1 gene and HIS3, EF3, CDC3 microsatellites and antifungal susceptibility profiles of Candida albicans isolates from Yaoundé HIV-infected patients,
Med. Mycol., vol. 55, no 5, p. 546‑554, juill. 2017. doi: 10.1093/mmy/myw108.

Bonnet M., Nansumba M., Bastard M., Orikiriza P., Kyomugasho N., Nansera D., Boum Y., de Beaudrap P., Kiwanuka J., et Kumbakumba E.,
Outcome of Children with Presumptive Tuberculosis in Mbarara, Rural Uganda,
Pediatr. Infect. Dis. J., vol. 37, no 2, p. 147‑152, août 2017. doi: 10.1097/INF.0000000000001727.

Pion S., Njiokou F., Boussinesq M., Simo G. et Truc P.,
Confirmation of No Influence of Loa loa and Mansonella perstans on the Card Agglutination Test for Trypanosomosis used for Serological Screening of Human African Trypanosomosis,
Journal of Tropical Diseases & Public Health, vol. 2017, août 2017. doi: 10.4172/2329-891X.1000242.

Ndongo F. A., Texier G., Penda C. I., Tejiokem M. C., Ndiang S. T., Ndongo J.-A., Guemkam G., Sofeu C. L., Kfutwah A., Faye A., Msellati P., Warszawski J., et ANRS-PEDIACAM Study Group,
Virologic Response to Early Antiretroviral Therapy in HIV-Infected Infants: Evaluation After Two Years of Treatment in the Pediacam Study, Cameroon,
Pediatr. Infect. Dis. J., août 2017. doi: 10.1097/INF.0000000000001745.

Jordan M. R., Penazzato M., Cournil A., Vubil A., Jani I., Hunt G., Carmona S., Maphalala G., Mthethwa N., Watera C., Kaleebu P., Chakanyuka Musanhu C., Mtapuri-Zinyowera S., Dzangare J., Peeters M., Yang C., Parkin N., et Bertagnolio S.,
HIV drug resistance in African infants and young children newly diagnosed with HIV: a multicounty analysis,
Clin. Infect. Dis., août 2017. doi: 10.1093/cid/cix698.

Hotter D., Krabbe T., Reith E., Gawanbacht A., Rahm N., Ayouba A., Van Driessche B., Van Lint C., Peeters M., Kirchhoff F., et Sauter D.,
Primate lentiviruses use at least three alternative strategies to suppress NF-κB-mediated immune activation,
PLoS Pathog., vol. 13, no 8, p. e1006598, août 2017. doi: 10.1371/journal.ppat.1006598.

Hagen F., Lumbsch H. T., Arsenijevic V. A., Badali H., Bertout S., Billmyre R. B., Bragulat M. R., Cabañes F. J., Carbia M., Chakrabarti A., Chaturvedi S., Chaturvedi V., Chen M., Chowdhary A., Colom M.-F., Cornely O. A., Crous P. W., Cuétara M. S., Diaz M. R., Espinel-Ingroff A., Fakhim H., Falk R., Fang W., Herkert P. F., Rodríguez C. F., Fraser J. A., Gené J., Guarro J., Idnurm A., Illnait-Zaragozi M.-T., Khan Z., Khayhan K., Kolecka A., Kurtzman C. P., Lagrou K., Liao W., Linares C., Meis J. F., Nielsen K., Nyazika T. K., Pan W., Pekmezovic M., Polacheck I., Posteraro B., Telles F. de Q., Romeo O., Sánchez M., Sampaio A., Sanguinetti M., Sriburee P., Sugita T., Taj-Aldeen S. J., Takashima M., Taylor J. W., Theelen B., Tomazin R., Verweij P. E., Wahyuningsih R., Wang P., et Boekhout T.,
Importance of Resolving Fungal Nomenclature: the Case of Multiple Pathogenic Species in the Cryptococcus Genus,
mSphere, vol. 2, no 4, p. e00238-17, août 2017. doi: 10.1128/mSphere.00238-17.

Lourenço J., Maia de Lima M., Faria N. R., Walker A., Kraemer M. U., Villabona-Arenas C. J., Lambert B., Marques de Cerqueira E., Pybus O. G., Alcantara L. C., et Recker M.,
Epidemiological and ecological determinants of Zika virus transmission in an urban setting,
Elife, vol. 6, 09 2017. doi: 10.7554/eLife.29820.

Ciaffi L., Koulla-Shiro S., Sawadogo A. B., Ndour C. T., Eymard-Duvernay S., Mbouyap P. R., Ayangma L., Zoungrana J., Gueye N. F. N., Diallo M., Izard S., Bado G., Kane C. T., Aghokeng A. F., Peeters M., Girard P. M., Le Moing V., Reynes J., Delaporte E., et MOBIDIP study group,
Boosted protease inhibitor monotherapy versus boosted protease inhibitor plus lamivudine dual therapy as second-line maintenance treatment for HIV-1-infected patients in sub-Saharan Africa (ANRS12 286/MOBIDIP): a multicentre, randomised, parallel, open-label, superiority trial,
Lancet HIV, vol. 4, no 9, p. e384‑e392, sept. 2017. doi: 10.1016/S2352-3018(17)30069-3.

Mueller Y., Mpala Q., Kerschberger B., Rusch B., Mchunu G., Mazibuko S., et Bonnet M.,
Adherence, tolerability, and outcome after 36 months of isoniazid-preventive therapy in 2 rural clinics of Swaziland: A prospective observational feasibility study,
Medicine (Baltimore), vol. 96, no 35, p. e7740, sept. 2017. doi: 10.1097/MD.0000000000007740.

Chesnais C., Awaca-Uvon N.-P., Bolay F., Boussinesq M., Fischer P., Gankpala L., Meite A., Missamou F., Pion S., et Weil G.,
A multi-center field study of two point of care tests for circulating Wuchereria bancrofti antigenemia in Africa
PLoS Neglected Tropical Diseases, vol. 11, no 9, p. e0005703, sept. 2017. doi: 10.1371/journal.pntd.0005703.

Raffi F., Hanf M., Ferry T., Khatchatourian L., Joly V., Pugliese P., Katlama C., Robineau O., Chirouze C., Jacomet C., Delobel P., Poizot-Martin I., Ravaux I., Duvivier C., Gagneux-Bugnon A., Rey D., Reynes J., May T., Bani-Sadr F., Hoen B., Morrier M., Cabie A., Allavena C., et Dat’AIDS Study Group,
Impact of baseline plasma HIV-1 RNA and time to virological suppression on virological rebound according to first-line antiretroviral regimen,
J. Antimicrob. Chemother., sept. 2017. doi: 10.1093/jac/dkx300.

Desclaux A. et Anoko J.,
[Anthropology engaged against Ebola (2014-2016): approaches, contributions and new questions],
Sante Publique, vol. 29, no 4, p. 477‑485, 02 2017. doi: 10.3917/spub.174.0477.

Cogliati M., Puccianti E., Montagna M. T., De Donno A., Susever S., Ergin C., Velegraki A., Ellabib M. S., Nardoni S., Macci C., Trovato L., Dipineto L., Rickerts V., Akcaglar S., Mlinaric-Missoni E., Bertout S., Vencà A. C. F., Sampaio A. C., Criseo G., Ranque S., Çerikçioğlu N., Marchese A., Vezzulli L., Ilkit M., Desnos-Ollivier M., Pasquale V., Polacheck I., Scopa A., Meyer W., Ferreira-Paim K., Hagen F., Boekhout T., Dromer F., Varma A., Kwon-Chung K. J., Inácio J., et Colom M. F.,
Fundamental niche prediction of the pathogenic yeasts Cryptococcus neoformans and Cryptococcus gattii in Europe,
Environ. Microbiol., sept. 2017. doi: 10.1111/1462-2920.13915.

Guichet E., Serrano L., Laurent C., Eymard-Duvernay S., Kuaban C., Vidal L., Delaporte E., Ngole E. M., Ayouba A., et Peeters M.,
Comparison of different nucleic acid preparation methods to improve specific HIV-1 RNA isolation for viral load testing on dried blood spots,
J. Virol. Methods, vol. 251, p. 75‑79, oct. 2017. doi: 10.1016/j.jviromet.2017.10.014.

Eyebe S., Sabbagh A., Pion S. D., Nana-Djeunga H. C., Kamgno J., Boussinesq M., et Chesnais C. B.,
Familial aggregation and heritability of Loa loa microfilaremia,
Clin. Infect. Dis., vol. 66, no 5, p. 751‑757, oct. 2017. doi: 10.1093/cid/cix877.

Niama F. R., Vidal N., Diop-Ndiaye H., Nguimbi E., Ahombo G., Diakabana P., Kombo É. S. B., Mayengue P. I., Kobawila S.-C., Parra H. J., et Toure-Kane C.,
HIV-1 genetic diversity and primary drug resistance mutations before large-scale access to antiretroviral therapy, Republic of Congo,
BMC Research Notes, déc. 2017. doi: 10.1186/s13104-017-2550-8.

Landefeld C. C., Fomenou L. A., Ateba F., et Msellati P.,
Prevention of Mother-to-Child Transmission of HIV in Yaounde: Barrier to Care,
AIDS Care, p. 1‑5, oct. 2017. doi: 10.1080/09540121.2017.1390540.

Ayouba A., Michem A., Peeters M., et Vercammen F.,
Full-Genome Characterization of Simian T-Cell Leukemia Virus Type 1 Subtype b from a Wild-Born Captive Gorilla gorilla gorilla with T-Cell Lymphoma,
Genome Announc, vol. 5, no 43, oct. 2017. doi: 10.1128/genomeA.01117-17.

Charpentier C., Montes B., Perrier M., Meftah N., et Reynes J.,
HIV-1 DNA ultra-deep sequencing analysis at initiation of the dual therapy dolutegravir + lamivudine in the maintenance DOLULAM pilot study,
J. Antimicrob. Chemother., vol. 72, no 10, p. 2831‑2836, oct. 2017. doi: 10.1093/jac/dkx233.

Kamgno J., Pion S. D., Chesnais C. B., Bakalar M. H., D’Ambrosio M. V., Mackenzie C. D., Nana-Djeunga H. C., Gounoue-Kamkumo R., Njitchouang G.-R., Nwane P., Tchatchueng-Mbouga J. B., Wanji S., Stolk W. A., Fletcher D. A., Klion A. D., Nutman T. B., et Boussinesq M.,
A Test-and-Not-Treat Strategy for Onchocerciasis in Loa loa-Endemic Areas,
N. Engl. J. Med., nov. 2017. doi: 10.1056/NEJMoa1705026.

Kabore F. N., Eymard-Duvernay S., Zoungrana J., Badiou S., Bado G., Héma A., Diouf A., Delaporte E., Koulla-Shiro S., Ciaffi L., et Cournil A.,
TDF and quantitative ultrasound bone quality in African patients on second line ART, ANRS 12169 2LADY sub-study,
PLoS ONE, vol. 12, no 11, p. e0186686, 2017. doi: 10.1371/journal.pone.0186686.

Liu W., Sherrill-Mix S., Learn G. H., Scully E. J., Li Y., Avitto A. N., Loy D. E., Lauder A. P., Sundararaman S. A., Plenderleith L. J., Ndjango J.-B. N., Georgiev A. V., Ahuka-Mundeke S., Peeters M., Bertolani P., Dupain J., Garai C., Hart J. A., Hart T. B., Shaw G. M., Sharp P. M., et Hahn B. H.,
Wild bonobos host geographically restricted malaria parasites including a putative new Laverania species,
Nat Commun, vol. 8, nov. 2017. doi: 10.1038/s41467-017-01798-5.

Marcy O., Tejiokem M., Msellati P., Truong Huu K., Do Chau V., Tran Ngoc D., Nacro B., Ateba-Ndongo F., Tetang-Ndiang S., Ung V., Dim B., Neou L., Berteloot L., Borand L., Delacourt C., Blanche S., et ANRS 12229 PAANTHER 01 Study Group,
Mortality and its determinants in antiretroviral treatment-naive HIV-infected children with suspected tuberculosis: an observational cohort study,
Lancet HIV, vol. 5, no 2, p. e87‑e95, nov. 2017. doi: 10.1016/S2352-3018(17)30206-0.

Peyriere H., Makinson A., Marchandin H., et Reynes J.,
Doxycycline in the management of sexually transmitted infections,
J. Antimicrob. Chemother., nov. 2017. doi: 10.1093/jac/dkx420.

Makinson A., Hayot M., Eymard-Duvernay S., Ribet C., Raffi F., Pialoux G., Zucman D., Poizot-Martin I., Bonnet F., Abgrall S., Tattevin P., Cheret A., Ferry T., Mauboussin J.-M., Marchand L., Rouzaud C., Reynes J., Zins M., Le Moing V., et ANRS EP48 HIV CHEST study Team,
HIV is associated with airway obstruction: a matched controlled study,
AIDS, vol. 32, no 2, p. 227‑232, nov. 2017. doi: 10.1097/QAD.0000000000001691.

Sams K., Desclaux A., Anoko J., Akindès F., Egrot M., Sow K., Taverne B., Bila B., Cros M., Keïta-Diop M., Fribault M., et Wilkinson A.,
Mobilising experience from Ebola to address plague in Madagascar and future epidemics,
The Lancet, vol. 0, no 0, nov. 2017. doi: 10.1016/S0140-6736(17)33088-X.

Gupta R. K., Gregson J., Parkin N., Haile-Selassie H., Tanuri A., Andrade Forero L., Kaleebu P., Watera C., Aghokeng A., Mutenda N., Dzangare J., Hone S., Hang Z. Z., Garcia J., Garcia Z., Marchorro P., Beteta E., Giron A., Hamers R., Inzaule S., Frenkel L. M., Chung M. H., de Oliveira T., Pillay D., Naidoo K., Kharsany A., Kugathasan R., Cutino T., Hunt G., Avila Rios S., Doherty M., Jordan M. R., et Bertagnolio S.,
HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta-regression analysis,
Lancet Infect Dis, nov. 2017. doi: 10.1016/S1473-3099(17)30702-8.

Virlogeux V., Zoulim F., Pugliese P., Poizot-Martin I., Valantin M.-A., Cuzin L., Reynes J., Billaud E., Huleux T., Bani-Sadr F., Rey D., Frésard A., Jacomet C., Duvivier C., Cheret A., Hustache-Mathieu L., Hoen B., Cabié A., Cotte L., et Dat’AIDS Study Group,
Modeling HIV-HCV coinfection epidemiology in the direct-acting antiviral era: the road to elimination,
BMC Med, vol. 15, no 1, p. 217, déc. 2017. doi: 10.1186/s12916-017-0979-1.

Kaiser C. et Pion S. D. S.,
River blindness goes beyond the eye: autoimmune antibodies, cross-reactive with Onchocerca volvulus antigen, detected in brain of patients with Nodding syndrome,
Ann Transl Med, vol. 5, no 23, p. 459, déc. 2017. doi: 10.21037/atm.2017.08.35.

Micollier E.,
Femininities on transnational journeys and sexual health risk : experiences of Chinese immigrant women in Canada,
Gender, Place and Culture, vol. 24, no 12, p. 1787‑1806, 2017. doi: 10.1080/0966369X.2017.1400952.